SAMG news

Quarterly discretionary assets under management decreased to $23.8 billion due to market weakness, but the company delivered firm's best net flows of 2026 and is restructuring non-discretionary reporting.

Sangamo Therapeutics, Inc. has filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware, resulting in the appointment of an examiner to investigate claims by creditors.

Silvercrest Asset Management announced it will hold a conference call to discuss Q3 2026 financial results on October 30. Key executives will host the event to review quarterly performance and discuss assets under management.

The company will release Q2 financial results and host a teleconference at 8:30 am ET, providing insight into its earnings performance.

Silvercrest Asset Management Group and its subsidiaries entered into a second amendment to their credit agreement dated June 18, 2026, with City National Bank, with $10 million in term loans outstanding and a $15,000 amendment fee. The amendment modifies terms of the existing credit facility and inc…